Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Turcot syndrome 1Lymphatic Metastasis 1

Interventions

Blood Specimen Collection 14Surveys and Questionnaires 13Specimen Handling 9Radiotherapy 5Magnetic Resonance Spectroscopy 5Immune Checkpoint Inhibitors 4Biopsy 4ribociclib 3Watchful Waiting 3Surgical Procedures, Operative 3Standard of Care 3Patient Reported Outcome Measures 3Observation 3Mental Status and Dementia Tests 3Genetic Testing 3Data Collection 3trastuzumab deruxtecan 2palbociclib 2darolutamide 2atezolizumab 2X-Rays 2Ultrasonography 2Tomography, X-Ray Computed 2Sulfonylurea Compounds 2Mass Screening 2Interviews as Topic 2Insulin 2Hepatectomy 2Fulvestrant 2Fluorodeoxyglucose F18 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × DNA Mismatch Repair × 30 days × Clear all
NCT07625735 2026-06-04

MMR Status Modulates the Predictive Value of Lymphatic Invasion for Lymph Node Metastasis in Gastric Cancer

Shanghai Zhongshan Hospital

Not yet recruiting
3,000 enrolled

Turcot syndrome, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡